CC BY-NC 4.0 · Arch Plast Surg 2017; 44(05): 370-377
DOI: 10.5999/aps.2017.44.5.370
Original Article

Effects of Human Adipose-Derived Stem Cells on the Survival of Rabbit Ear Composite Grafts

Chae Min Kim
Department of Plastic and Reconstructive Surgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea
,
Joo Hyun Oh
Institute for Human Tissue Restoration, Department of Plastic and Reconstructive Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
,
Yeo Reum Jeon
Department of Plastic and Reconstructive Surgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea
,
Eun Hye Kang
Institute for Human Tissue Restoration, Department of Plastic and Reconstructive Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
,
Dae Hyun Lew
Institute for Human Tissue Restoration, Department of Plastic and Reconstructive Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
› Author Affiliations

Background Composite grafts are frequently used for facial reconstruction. However, the unpredictability of the results and difficulties with large defects are disadvantages. Adipose-derived stem cells (ADSCs) express several cytokines, and increase the survival of random flaps and fat grafts owing to their angiogenic potential.

Methods This study investigated composite graft survival after ADSC injection. Circular chondrocutaneous composite tissues, 2 cm in diameter, from 15 New Zealand white rabbits were used. Thirty ears were randomly divided into 3 groups. In the experimental groups (1 and 2), ADSCs were subcutaneously injected 7 days and immediately before the operation, respectively. Similarly, phosphate-buffered saline was injected in the control group just before surgery in the same manner as in group 2. In all groups, chondrocutaneous composite tissue was elevated, rotated 90 degrees, and repaired in its original position. Skin flow was assessed using laser Doppler 1, 3, 6, 9, and 12 days after surgery. At 1 and 12 days after surgery, the viable area was assessed using digital photography; the rabbits were euthanized, and immunohistochemical staining for CD31 was performed to assess neovascularization.

Results The survival of composite grafts increased significantly with the injection of ADSCs (P<0.05). ADSC injection significantly improved neovascularization based on anti-CD31 immunohistochemical analysis and vascular endothelial growth factor expression (P<0.05) in both group 1 and group 2 compared to the control group. No statistically significant differences in graft survival, anti-CD31 neovascularization, or microcirculation were found between groups 1 and 2.

Conclusions Treatment with ADSCs improved the composite graft survival, as confirmed by the survival area and histological evaluation. The differences according to the injection timing were not significant.



Publication History

Received: 18 April 2017

Accepted: 29 August 2017

Article published online:
20 April 2022

© 2017. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • REFERENCES

  • 1 Cheon YW, Park BY. Long-term evaluation of elongating columella using conchal composite graft in bilateral secondary cleft lip and nose deformity. Plast Reconstr Surg 2010; 126: 543-53
  • 2 Son D, Kwak M, Yun S. et al. Large auricular chondrocutaneous composite graft for nasal alar and columellar reconstruction. Arch Plast Surg 2012; 39: 323-8
  • 3 Jeon YR, Kang EH, Yang CE. et al. The effect of platelet-rich plasma on composite graft survival. Plast Reconstr Surg 2014; 134: 239-46
  • 4 Harbison JM, Kriet JD, Humphrey CD. Improving outcomes for composite grafts in nasal reconstruction. Curr Opin Otolaryngol Head Neck Surg 2012; 20: 267-73
  • 5 Li EN, Menon NG, Rodriguez ED. et al. The effect of hyperbaric oxygen therapy on composite graft survival. Ann Plast Surg 2004; 53: 141-5
  • 6 Rubina K, Kalinina N, Efimenko A. et al. Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Tissue Eng Part A 2009; 15: 2039-50
  • 7 Sterodimas A, de Faria J, Nicaretta B. et al. Tissue engineering with adipose-derived stem cells (ADSCs): current and future applications. J Plast Reconstr Aesthet Surg 2010; 63: 1886-92
  • 8 Lu F, Mizuno H, Uysal CA. et al. Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg 2008; 121: 50-8
  • 9 Yue Y, Zhang P, Liu D. et al. Hypoxia preconditioning enhances the viability of ADSCs to increase the survival rate of ischemic skin flaps in rats. Aesthetic Plast Surg 2013; 37: 159-70
  • 10 Lu F, Li J, Gao J. et al. Improvement of the survival of human autologous fat transplantation by using VEGF-transfected adipose-derived stem cells. Plast Reconstr Surg 2009; 124: 1437-46
  • 11 Choi CM, Bennett RG. Laser Dopplers to determine cutaneous blood flow. Dermatol Surg 2003; 29: 272-80
  • 12 Ko SH, Nauta A, Wong V. et al. The role of stem cells in cutaneous wound healing: what do we really know?. Plast Reconstr Surg 2011; 127 Suppl 1: 10S-20S
  • 13 Nauta AC, Gurtner GC, Longaker MT. Adult stem cells in small animal wound healing models. Methods Mol Biol 2013; 1037: 81-98
  • 14 Hocking AM. Mesenchymal Stem Cell Therapy for Cutaneous Wounds. Adv Wound Care (New Rochelle) 2012; 1: 166-71
  • 15 Hanson SE, Bentz ML, Hematti P. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg 2010; 125: 510-6
  • 16 Chen L, Tredget EE, Wu PY. et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008; 3: e1886
  • 17 Behr B, Ko SH, Wong VW. et al. Stem cells. Plast Reconstr Surg 2010; 126: 1163-71
  • 18 De Ugarte DA, Alfonso Z, Zuk PA. et al. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett 2003; 89: 267-70
  • 19 Ishikawa T, Banas A, Hagiwara K. et al. Stem cells for hepatic regeneration: the role of adipose tissue derived mesenchymal stem cells. Curr Stem Cell Res Ther 2010; 5: 182-9
  • 20 Gir P, Oni G, Brown SA. et al. Human adipose stem cells: current clinical applications. Plast Reconstr Surg 2012; 129: 1277-90
  • 21 Haddad-Mashadrizeh A, Bahrami AR, Matin MM. et al. Human adipose-derived mesenchymal stem cells can survive and integrate into the adult rat eye following xenotransplantation. Xenotransplantation 2013; 20: 165-76
  • 22 Yucel E, Alagoz MS, Eren GG. et al. Use of Adipose-Derived Mesenchymal Stem Cells to Increase Viability of Composite Grafts. J Craniofac Surg 2016; 27: 1354-60
  • 23 Oh JS, Ha Y, An SS. et al. Hypoxia-preconditioned adipose tissue-derived mesenchymal stem cell increase the survival and gene expression of engineered neural stem cells in a spinal cord injury model. Neurosci Lett 2010; 472: 215-9